[A case of long-term survival of unresectable-advanced gastric cancer due to chemotherapy]

Gan To Kagaku Ryoho. 2009 Nov;36(12):2281-3.
[Article in Japanese]

Abstract

The case was a 50s male with chief complaints of body weight loss and nausea. A clinical finding was Stage IV gastric cancer of poorly differentiated adenocarcinoma. We diagnosed it unresectable and started 5-FU+CDDP as the first-line chemotherapy. Partial response (PR) was observed and progression free time was 7 months. After 9 courses of 5-FU+ CDDP, the tumor grew and an oral intake was getting impossible. Gastro-jejunostomy was performed and then started a weekly PTX as the second-line chemotherapy after operation. The response was progressive disease (PD) after 4 courses of weekly PTX. Then we started S-1+CPT-11 as the third-line chemotherapy. We could continue S-1+CPT-11 for 9 courses without a severe adverse effect. Overall survival was 26.2 months.

Publication types

  • Case Reports

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Antimetabolites, Antineoplastic / administration & dosage
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Camptothecin / administration & dosage
  • Camptothecin / analogs & derivatives
  • Cisplatin / administration & dosage
  • Drug Combinations
  • Fluorouracil / administration & dosage
  • Humans
  • Irinotecan
  • Male
  • Middle Aged
  • Oxonic Acid / administration & dosage
  • Stomach Neoplasms / drug therapy*
  • Tegafur / administration & dosage

Substances

  • Antimetabolites, Antineoplastic
  • Antineoplastic Agents, Phytogenic
  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Irinotecan
  • Cisplatin
  • Fluorouracil
  • Camptothecin